Spectrum Science Acquires Return on Focus

September 30, 2025

Spectrum Science has acquired Return on Focus, a strategic marketing consultancy that provides evidence-based brand positioning and strategic services to pharmaceutical and biotech companies. The acquisition strengthens Spectrum’s strategic and commercial capabilities—bringing Return on Focus’ data-driven positioning expertise into Spectrum’s integrated healthcare marketing platform; Dan Reinhardt and Abby Manning will continue to lead the ROF team.

Buyers
Spectrum Science
Targets
Return on Focus
Platforms
Spectrum Science
Location
New Jersey, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.